• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酪蛋白抑肽类似物硼酸衍生物的构效关系:蛋白酶体抑制剂。

Structure-activity relationship of boronic acid derivatives of tyropeptin: proteasome inhibitors.

机构信息

Institute of Microbial Chemistry, Tokyo, Tokyo 141-0021, Japan.

出版信息

Bioorg Med Chem Lett. 2010 Oct 1;20(19):5839-42. doi: 10.1016/j.bmcl.2010.07.122. Epub 2010 Aug 1.

DOI:10.1016/j.bmcl.2010.07.122
PMID:20727746
Abstract

The structure-activity relationship of the boronic acid derivatives of tyropeptin, a proteasome inhibitor, was studied. Based on the structure of a previously reported boronate analog of tyropeptin (2), 41 derivatives, which have varying substructure at the N-terminal acyl moiety and P2 position, were synthesized. Among them, 3-phenoxyphenylacetamide 6 and 3-fluoro picolinamide 22 displayed the most potent inhibitory activity toward chymotryptic activity of proteasome and cytotoxicity, respectively. The replacement of the isopropyl group in the P2 side chain to H or Me had negligible effects on the biological activities examined in this study.

摘要

研究了蛋白酶体抑制剂酪蛋白肽硼酸衍生物的构效关系。基于先前报道的酪蛋白肽硼酸类似物(2)的结构,合成了 41 种具有不同 N 端酰基部分和 P2 位取代基的衍生物。其中,3-苯氧基苯甲酰胺 6 和 3-氟吡啶酰胺 22 对蛋白酶体的糜蛋白酶活性和细胞毒性表现出最强的抑制活性。在本研究中,P2 侧链中异丙基取代为 H 或 Me 对所研究的生物活性几乎没有影响。

相似文献

1
Structure-activity relationship of boronic acid derivatives of tyropeptin: proteasome inhibitors.酪蛋白抑肽类似物硼酸衍生物的构效关系:蛋白酶体抑制剂。
Bioorg Med Chem Lett. 2010 Oct 1;20(19):5839-42. doi: 10.1016/j.bmcl.2010.07.122. Epub 2010 Aug 1.
2
Synthesis of boronic acid derivatives of tyropeptin: proteasome inhibitors.酪肽硼酸盐衍生物的合成:蛋白酶体抑制剂
Bioorg Med Chem Lett. 2009 Apr 15;19(8):2343-5. doi: 10.1016/j.bmcl.2009.02.117. Epub 2009 Mar 4.
3
Design, synthesis, biological evaluation, and structure-activity relationship (SAR) discussion of dipeptidyl boronate proteasome inhibitors, part I: comprehensive understanding of the SAR of alpha-amino acid boronates.二肽基硼酸酯蛋白酶体抑制剂的设计、合成、生物学评价及构效关系(SAR)探讨,第一部分:对α-氨基酸硼酸酯构效关系的全面理解
J Med Chem. 2009 Jul 23;52(14):4192-9. doi: 10.1021/jm9005093.
4
Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome.基于结构的酪氨酸肽A衍生物设计,作为哺乳动物20S蛋白酶体的强效和选择性抑制剂。
Bioorg Med Chem Lett. 2005 Apr 1;15(7):1867-71. doi: 10.1016/j.bmcl.2005.02.013.
5
Design, synthesis and biological evaluation of tripeptide boronic acid proteasome inhibitors.三肽硼酸蛋白酶体抑制剂的设计、合成与生物评价。
Bioorg Med Chem. 2009 Oct 1;17(19):6851-61. doi: 10.1016/j.bmc.2009.08.023. Epub 2009 Aug 20.
6
Chemical and biological evaluation of dipeptidyl boronic acid proteasome inhibitors for use in prodrugs and pro-soft drugs targeting solid tumors.二肽硼酸蛋白酶体抑制剂的化学和生物学评价,用于针对实体瘤的前药和前软药。
J Med Chem. 2011 Jul 14;54(13):4365-77. doi: 10.1021/jm200460q. Epub 2011 Jun 20.
7
Synthesis and activity of tyropeptin A derivatives as potent and selective inhibitors of mammalian 20S proteasome.酪肽素A衍生物作为哺乳动物20S蛋白酶体有效且选择性抑制剂的合成与活性
Biosci Biotechnol Biochem. 2005 Sep;69(9):1733-42. doi: 10.1271/bbb.69.1733.
8
Synthesis, in vitro and in vivo biological evaluation, and comprehensive understanding of structure-activity relationships of dipeptidyl boronic acid proteasome inhibitors constructed from β-amino acids.从β-氨基酸构建的二肽硼酸蛋白酶体抑制剂的合成、体外和体内生物评价以及对构效关系的综合理解。
J Med Chem. 2010 Dec 23;53(24):8619-26. doi: 10.1021/jm1009742. Epub 2010 Nov 15.
9
Synthesis, in vitro and in vivo biological evaluation, docking studies, and structure--activity relationship (SAR) discussion of dipeptidyl boronic acid proteasome inhibitors composed of beta-amino acids.合成、体外和体内生物评价、对接研究以及由β-氨基酸组成的二肽硼酸蛋白酶体抑制剂的构效关系(SAR)讨论。
J Med Chem. 2010 Mar 11;53(5):1990-9. doi: 10.1021/jm901407s.
10
Identification of a potent and rapidly reversible inhibitor of the 20S-proteasome.一种20S蛋白酶体强效且快速可逆抑制剂的鉴定。
Bioorg Med Chem Lett. 2004 Sep 20;14(18):4701-4. doi: 10.1016/j.bmcl.2004.06.084.

引用本文的文献

1
Natural product scaffolds as inspiration for the design and synthesis of 20S human proteasome inhibitors.天然产物骨架作为设计和合成20S人蛋白酶体抑制剂的灵感来源。
RSC Chem Biol. 2020 Dec 1;1(5):305-332. doi: 10.1039/d0cb00111b. Epub 2020 Sep 16.
2
Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitors.酪氨酸胜肽硼酸衍生物的抗肿瘤作用:新型蛋白酶体抑制剂。
Cancer Sci. 2014 Dec;105(12):1609-15. doi: 10.1111/cas.12542. Epub 2014 Oct 21.
3
Structural optimization, biological evaluation, and application of peptidomimetic prostate specific antigen inhibitors.
肽类前列腺特异抗原抑制剂的结构优化、生物学评价及应用。
J Med Chem. 2013 Jun 13;56(11):4224-35. doi: 10.1021/jm301718c. Epub 2013 Jun 4.
4
Combined 3D-QSAR, molecular docking and molecular dynamics study on derivatives of peptide epoxyketone and tyropeptin-boronic acid as inhibitors against the β5 subunit of human 20S proteasome.肽环氧酮和酪蛋白硼酸酸衍生物作为人20S蛋白酶体β5亚基抑制剂的联合3D-QSAR、分子对接和分子动力学研究
Int J Mol Sci. 2011;12(3):1807-35. doi: 10.3390/ijms12031807. Epub 2011 Mar 9.